readingfram
mainten
crucial
translat
fidel
ensur
codon
correct
readingfram
mrna
deliveri
site
elong
ribosom
howev
function
translat
frameshift
program
sitespecif
particular
mrna
varieti
mobil
element
well
virus
cellular
gene
specif
program
sequenc
structur
mrna
caus
fraction
elong
ribosom
shift
nt
mrna
lead
program
readingfram
shift
prf
wherea
frameshift
occur
ribosom
slip
toward
nt
addit
infram
translat
product
frameshift
event
thu
allow
synthesi
extra
protein
ntermin
ctermin
region
separ
shift
site
encod
shift
frame
respect
mani
virus
requir
frameshift
decod
crucial
viral
gene
reli
prf
effici
control
ratio
viral
protein
optim
viral
propag
effici
eukaryot
prf
requir
two
cisact
element
mrna
slipperi
sequenc
frameshift
occur
optim
place
downstream
stimul
structur
xxxyyyz
sequenc
slipperi
site
facilit
frameshift
pave
codonanticodon
disrupt
p
site
xxi
yyz
codon
codonanticodon
repair
frame
xxx
yyy
codon
transit
enhanc
resist
downstream
stimul
usual
pseudoknot
hairpin
duplex
unwind
activ
ribosom
lead
interfer
transloc
step
elong
cycl
addit
space
nucleotid
number
slipperi
site
downstream
stimul
affect
prf
effici
help
posit
slipperi
site
p
site
elong
ribosom
downstream
stimul
approach
mrna
entri
channel
ribosom
propos
tension
creat
unwind
stimul
codonanticodon
interact
network
anchor
around
ribosom
p
site
shift
frame
reliev
tension
overcom
ribosom
paus
impos
stimul
interestingli
basepair
interact
intern
shinedalgarno
sd
like
sequenc
upstream
frameshift
site
antisd
sequenc
ribosom
rna
also
act
frameshift
regul
ribosom
could
due
tension
translat
paus
mediat
upstream
mediat
duplex
mutagenesi
viral
prf
signal
chang
prf
effici
shown
impair
replic
sever
virus
includ
hiv
sever
acut
respiratori
syndrom
coronaviru
sarscov
suggest
viral
prf
regul
potenti
antivir
mean
given
crucial
role
prf
effici
viral
replic
differ
strategi
develop
target
viral
prf
stimul
explor
potenti
antivir
applic
small
ligand
capabl
interf
viral
prf
activ
bind
downstream
prf
stimul
hiv
sarscov
identifi
either
screen
structurebas
design
altern
antisens
peptid
nucleic
acid
pna
target
viral
prf
stimul
pseudoknot
shown
impair
replic
sarscov
replicon
approach
function
character
viral
prf
stimul
requir
may
repres
bottleneck
combat
emerg
epidem
viral
pathogen
merscov
recent
rna
hairpin
upstream
frameshift
site
sarscov
shown
attenu
prf
depend
hairpin
stabil
optim
spacer
length
slipperi
site
hairpin
uniqu
upstream
hairpin
repres
first
cisel
capabl
downregul
eukaryot
prf
activ
understand
function
mechan
provid
insight
mechan
prf
regul
antivir
applic
potenti
upstream
attenu
hairpin
unwound
ribosom
ribosom
encount
downstream
stimul
propos
refold
dynam
hairpin
respons
prf
attenu
activ
found
duplex
form
anneal
antisens
dna
complementari
mrna
sequenc
upstream
prf
slipperi
site
could
attenu
prf
similar
extent
upstream
hairpin
attenu
cisform
upstream
hairpin
replac
transform
duplex
suggest
upstream
duplex
format
determin
element
prf
attenu
find
reminisc
frameshift
regul
mediat
short
upstream
duplex
ribosom
provid
insight
function
mechan
upstream
prf
attenu
ribosom
furthermor
appli
upstream
duplex
attenu
counteract
sever
viral
prf
signal
demonstr
gener
applic
potenti
altern
prf
inhibit
approach
thu
inhibit
prf
antisensemedi
upstream
duplex
provid
potenti
quick
antivir
solut
emerg
highli
pathogen
coronavirus
opportun
sequencespecif
regul
prf
relat
cellular
event
use
two
differ
prf
report
analyz
frameshift
effici
studi
recod
report
gift
professor
john
atkin
univers
utah
use
radioact
base
vitro
translat
well
dualluciferas
base
measur
vitro
translat
cell
frameshift
effici
calcul
addit
variant
engin
facilit
radioact
base
prf
activ
analysi
vitro
variant
contain
prematur
frame
stop
codon
nt
downstream
bamhi
site
translat
shorten
frame
product
reticulocyt
lysat
prf
element
use
studi
contain
differ
viral
downstream
prf
stimul
upstream
sequenc
flank
slipperi
site
construct
assembl
differ
piec
chemic
synthes
dna
oligonucleotid
partial
overlap
sequenc
via
polymeras
chain
reaction
pcr
base
ligat
approach
forward
revers
dna
primer
respect
carri
sali
bamhi
restrict
site
appropri
design
anneal
sequenc
use
pcr
amplif
cdna
encod
viral
prf
element
interest
amplifi
insert
encod
distinct
viral
prf
signal
clone
salibamhi
site
appropri
prf
report
clone
perform
use
standard
procedur
result
recombin
prf
report
transform
strain
escherichia
coli
cell
mainten
select
ampicillin
mutagenesi
introduc
desir
posit
use
quickchang
mutagenesi
kit
stratagen
accord
manufactur
instruct
ident
clone
mutat
prf
element
confirm
dna
sequenc
analysi
synthet
rna
use
studi
transcrib
rna
polymeras
design
dna
templat
use
vitro
transcript
method
transcrib
rna
purifi
denatur
polyacrylamid
gel
electrophoresi
presenc
urea
gel
band
contain
desir
rna
cut
electroelut
use
biotrap
devic
schleicher
schuell
elut
rna
ethanol
precipit
recov
centrifug
antisens
dna
oligonucleotid
chemic
synthes
purchas
mission
biotech
taiwan
wherea
omemodifi
rna
oligonucleotid
purchas
trilink
biotechnolog
inc
usa
concentr
oligonucleotid
determin
uv
absorb
cell
cultur
dulbecco
modifi
eagl
medium
gibco
supplement
fetal
bovin
serum
fb
gibco
dish
confluenc
cell
transfer
dish
incub
confluenc
wash
icecold
phosphatebuff
salin
pb
detach
trypsin
use
trypsinedta
trypsin
mm
edta
gibco
stop
trypsin
medium
contain
fb
corn
detach
cell
centrifug
g
pellet
cell
cell
pellet
wash
twice
pb
resuspend
hypoton
buffer
mm
hepe
mm
potassium
acet
mm
magnesium
acet
mm
dithiothreiol
dtt
proteinas
inhibitor
cocktail
roch
resuspend
cell
pellet
incub
ice
min
homogen
ml
syring
use
g
needl
centrifug
g
min
supernat
contain
cell
lysat
collect
content
protein
concentr
measur
bradford
assay
biorad
store
human
embryon
kidney
cell
cultur
describ
one
day
transfect
cell
per
well
plate
cultur
plate
growth
medium
transfect
carri
ad
mixtur
plasmid
dna
transfect
reagent
polyplu
well
accord
manufactur
instruct
luciferas
activ
measur
transfect
cell
lysat
perform
describ
cap
viral
prf
report
mrna
prepar
use
mmessag
mmachin
highyield
cap
rna
transcript
kit
ambion
follow
manufactur
instruct
reticulocyt
lysat
ambion
well
human
cell
lysat
use
gener
shift
nonshift
protein
product
frameshift
analysi
radioactivitybas
assay
reticulocyt
lysat
total
reaction
contain
ng
cap
report
mrna
translat
lysat
methionin
nen
incub
h
vitro
translat
sampl
resolv
sodium
dodecylsulphatepolyacrylamid
gel
electrophoresi
expos
phosphorimag
screen
quantif
dri
frameshift
effici
calcul
divid
count
shift
product
sum
count
shift
nonshift
product
calibr
methionin
content
protein
product
present
radioactivitybas
vitro
prf
result
term
rel
prf
activ
ribosom
dropoff
effect
remov
procedur
vitro
dualluciferas
base
prf
assay
perform
reticulocyt
lysat
human
cell
lysat
describ
experi
vitro
translat
reaction
use
cell
lysat
reaction
contain
cell
lysat
ng
rna
templat
translat
buffer
mm
hepe
mm
potassium
acet
mm
magnesium
acet
mm
atp
mm
gtp
mm
creatinephosph
mgml
creatin
phosphokinas
mm
dtt
mm
spermidin
uml
rnasin
promega
reaction
incub
h
luciferas
activ
measur
perform
use
dual
report
assay
promega
accord
manufactur
instruct
multilabel
plate
reader
hidex
frameshift
effici
calcul
accord
previous
describ
procedur
readthrough
control
purifi
rna
transcript
treat
rapid
alkalin
phosphatas
roch
presenc
rnase
inhibitor
promega
h
remov
unlabel
inactiv
phosphatas
incub
min
amersham
polynucleotid
kinas
roch
ad
reaction
continu
min
label
rna
purifi
denatur
polyacrylamid
gel
recov
crush
soak
procedur
ethanol
precipit
label
rna
recov
centrifug
analyz
interact
label
rna
probe
cpm
per
reaction
incub
variou
amount
antisens
dna
final
volum
tbe
buffer
contain
mm
nacl
mm
edta
complex
heat
anneal
min
reaction
mix
sucros
load
buffer
load
nondenatur
polyacrylamid
gel
acryl
bisacryl
ratio
tbe
trisbor
acidedta
run
constant
voltag
emsa
analysi
result
visual
autoradiographi
use
typhoon
phosphorimag
ge
unless
otherwis
indic
experi
perform
triplic
rel
frameshift
activ
report
one
standard
deviat
mean
analysi
varianc
anova
set
data
without
differ
amount
antisens
perform
dataset
fvalu
bigger
critic
valu
lookup
tabl
pvalu
smaller
analyz
pairwis
comparison
comput
smallest
signific
differ
lsd
ttest
addit
extra
experiment
data
set
obtain
mer
prf
assay
human
cell
lysat
without
omemodifi
rna
antisens
compar
readthrough
control
supplementari
figur
perform
statist
analysi
suggest
dualluciferas
base
assay
figur
demonstr
format
upstream
attenu
hairpin
control
altern
basepair
scheme
achiev
prf
activ
regul
aim
sequencespecif
regul
prf
design
dna
oligonucleotid
complementari
sequenc
stem
potent
prf
attenu
hairpin
supplementari
figur
interfer
attenu
hairpin
refold
antisens
dna
design
form
either
bp
complementari
upstream
rna
target
gener
duplex
similar
stabil
measur
effect
antisens
attenu
effici
prf
report
contain
upstream
attenu
hairpin
downstream
sarscov
prf
pseudoknot
stimul
prf
attenu
track
decreas
prf
effici
observ
decreas
frame
orand
increas
frame
translat
product
upon
antisens
addit
prf
assay
interestingli
addit
result
dosedepend
loss
attenu
activ
consist
antisensemedi
attenu
hairpin
disrupt
wherea
addit
suppress
attenu
activ
figur
b
mean
prf
activ
opposit
control
intran
antisens
dna
oligonucleotid
design
target
either
side
stem
region
upstream
attenu
hairpin
provid
way
sequencespecif
regul
prf
one
possibl
explan
observ
opposit
effect
attenu
activ
modul
two
antisens
oligonucleotid
access
transduplex
format
differ
two
side
refold
hairpin
stem
presenc
nearbi
ribosom
altern
opposit
effect
may
caus
differ
space
slipperi
site
two
antisensemedi
duplex
given
proxim
play
import
role
attenu
effici
cisform
attenu
hairpin
consist
later
explan
addit
antisens
dna
restor
dna
sequenc
complementari
impair
attenu
hairpin
supplementari
figur
led
enhanc
attenu
prf
effici
report
contain
wt
dosedepend
manner
figur
impair
attenu
hairpin
share
sequenc
result
also
rule
access
issu
thu
find
indic
upstream
duplex
need
proxim
slipperi
site
effici
prf
attenu
suggest
duplex
proxim
upstream
hairpin
stem
function
unit
respons
frameshift
attenu
see
minim
requir
duplex
length
effect
upstream
attenu
duplex
three
antisens
variant
restor
restor
restor
potenti
form
duplex
bp
design
space
e
site
kept
prevent
esit
invas
occur
supplementari
figur
prf
attenu
activ
shortest
upstream
duplex
declin
dramat
compar
longest
upstream
duplex
mediat
antisens
figur
b
although
proxim
requir
function
upstream
prf
attenu
duplex
figur
b
suggest
observ
prf
attenu
result
ribosom
dropoff
translat
elong
ribosom
loss
observ
prf
attenu
activ
shorter
upstream
duplex
figur
b
impli
observ
prf
attenu
restor
could
caus
dropoff
effect
mediat
longer
upstream
duplex
particular
gel
base
assay
may
resolv
potenti
upstream
duplexmedi
dropoff
product
translat
product
eventu
could
result
amount
product
overestim
lead
underestim
prf
effici
address
issu
creat
new
construct
stop
codon
move
downstream
slipperi
site
supplementari
figur
help
distinguish
product
potenti
dropoff
product
appear
within
upstream
mrna
sequenc
target
antisens
trend
prf
attenu
effici
upstream
duplex
differ
length
use
construct
similar
one
use
figur
presenc
antisens
figur
indic
upstream
duplex
suffici
length
act
prf
attenu
note
attenu
effici
antisensemedi
upstream
duplex
figur
dramat
statist
signific
presenc
antisens
calcul
construct
carri
hairpin
possess
residu
prf
attenu
activ
nevertheless
result
confirm
prf
attenu
effect
gener
intran
antisens
dnamedi
upstream
duplex
proxim
slipperi
site
previous
shown
upstream
prf
attenu
hairpin
could
downregul
prf
stimul
distinct
downstream
stimul
see
upstream
duplex
use
attenu
viral
prf
stimul
sarscov
compar
frameshift
effici
sever
viral
prf
pseudoknot
stimul
includ
mous
mammari
tumor
viru
mmtv
simian
retroviru
srv
hairpin
stimul
deriv
srv
pseudoknot
supplementari
figur
presenc
differ
amount
antisens
target
upstream
sequenc
supplementari
figur
surprisingli
found
signific
prf
attenu
observ
presenc
antisens
compar
figur
could
explain
less
stabl
structur
form
upstream
slipperi
site
current
report
contrast
amount
frame
product
translat
readthrough
control
affect
furthermor
prf
activ
attenu
differ
extent
design
antisens
dna
differ
complementar
sequenc
upstream
slipperi
site
exampl
restor
need
attenu
similar
extent
srv
figur
f
restor
form
less
base
pair
upstream
sequenc
taken
togeth
result
indic
upstream
duplex
approach
provid
gener
mean
downregul
prf
activ
stimul
distinct
type
downstream
stimul
vitro
explor
potenti
upstream
duplexmedi
prf
attenu
antivir
applic
human
coronaviru
hcov
analyz
sequenc
upstream
slipperi
site
six
known
hcov
found
potenti
hairpin
stem
upstream
prf
slipperi
site
addit
one
character
sarscov
supplementari
figur
b
howev
prf
activ
shorten
report
contain
upstream
hairpin
sarscov
pseudoknot
attenu
effici
sarscov
attenu
hairpin
supplementari
figur
could
explain
less
stabl
free
energi
upstream
hairpin
predict
mfold
ask
antisensemedi
duplex
compet
predict
upstream
hairpin
gener
potent
prf
attenu
duplex
form
emsa
experi
indic
isol
upstream
rna
hairpin
supplementari
figur
form
complex
antisens
dna
target
sequenc
hairpin
supplementari
figur
suggest
format
duplex
figur
furthermor
addit
led
higher
prf
attenu
activ
cisform
viral
attenu
hairpin
alon
fulllength
prf
report
supplementari
figur
thu
preexist
local
conform
upstream
prf
slipperi
site
program
antisens
approach
gener
function
prf
attenu
form
transform
duplex
antisens
approach
appli
disrupt
downstream
prf
stimul
sarscov
howev
success
approach
requir
character
boundari
downstream
stimul
inform
may
avail
new
outbreak
pathogen
merscov
inde
found
sarscov
type
pseudoknot
type
kiss
hairpin
pseudoknot
might
exist
downstream
uuuaaac
prf
slipperi
site
merscov
supplementari
figur
b
addit
two
prf
report
contain
sequenc
delet
merscov
prf
signal
block
format
either
pseudoknot
supplementari
figur
possess
substanti
prf
activ
vitro
cell
figur
suggest
pseudoknot
may
function
viral
replic
although
contribut
either
pseudoknot
viral
prf
activ
requir
studi
omemodifi
rna
use
evalu
viral
prf
attenu
activ
antisensemedi
upstream
duplex
human
cell
lysat
dna
antisens
would
digest
crude
cellular
lysat
found
omemodifi
antisens
rna
oligonucleotid
capabl
mediat
upstream
duplex
format
supplementari
figur
effici
downregul
vitro
prf
activ
merscov
viral
sequenc
capabl
form
altern
downstream
stimul
dosagedepend
manner
human
cell
lysat
wherea
attenu
effect
neutral
coexist
antiantisens
supplementari
figur
figur
rigor
statist
analysi
recommend
base
assay
use
omemodifi
antisens
rna
readthrough
control
led
similar
extent
inhibit
figur
therefor
target
sequenc
upstream
slipperi
site
repres
effici
straightforward
approach
viral
prf
inhibit
detail
knowledg
downstream
stimul
boundari
requir
approach
use
look
quick
therapeut
solut
emerg
pathogen
merscov
stabl
structur
could
act
roadblock
caus
ribosom
dropoff
addit
stimul
prf
accordingli
frameshift
pseudoknot
prohibit
signific
fraction
frameshift
ribosom
stimul
reach
frame
stop
codon
eventu
lead
compromis
observ
prf
effici
contrast
transform
prf
attenu
duplex
identifi
work
upstream
slipperi
site
potenti
ribosom
dropoff
effect
mediat
duplex
occur
ribosom
reach
slipperi
site
dropoff
effect
could
lead
underestim
prf
effici
dropoff
product
could
distinguish
product
observ
experiment
design
move
stop
codon
away
locat
upstream
duplex
figur
clearli
clarifi
role
upstream
duplex
prf
attenu
furthermor
cisform
upstream
hairpin
transform
duplex
work
act
attenu
prf
stimul
varieti
downstream
stimul
ribosom
system
suggest
attenu
could
share
prf
attenu
mechan
previous
ribosom
e
site
adjac
duplex
form
intern
sdlike
element
upstream
slipperi
site
antisd
sequenc
rrna
shown
attenu
prokaryot
frameshift
effici
e
coli
contrast
intern
sd
promot
releas
factor
depend
frameshift
place
adjac
ribosom
e
site
opposit
role
frameshift
regul
led
suggest
tensionmedi
mechan
frameshift
stimul
altern
effect
could
caus
elong
paus
mediat
intern
interact
elong
ribosom
interestingli
previous
shown
upstream
hairpin
stimul
frameshift
yeast
addit
attenu
prf
vitro
translat
system
mechan
inci
refold
hairpin
well
transform
upstream
duplex
eukaryot
frameshift
regul
may
thu
relev
duplex
form
intern
sd
rrna
prokaryot
frameshift
regul
given
format
duplex
upstream
slipperi
site
involv
case
howev
move
attenu
hairpin
enhanc
prf
effici
manner
sdlike
stimul
element
possibl
reason
differ
intern
sdmediat
duplex
involv
ribosom
rna
compon
ribosom
part
translat
machineri
wherea
eukaryot
ribosom
lack
antisd
sequenc
due
differ
translat
system
antisensemedi
upstream
duplex
identifi
work
could
simpli
act
wheel
chock
block
ribosom
movement
trigger
downstream
prf
stimul
mediat
tension
effect
stimul
mechan
prf
best
analyz
ribosom
system
singlemolecul
experi
link
exist
downstream
prf
stimul
structur
modul
sever
molecular
event
within
transloc
cycl
ongo
work
test
transform
upstream
duplex
replac
function
intern
interact
ribosom
frameshift
regul
aim
establish
link
ribosom
frameshift
regul
via
upstream
duplex
differ
form
effect
trigger
downstream
stimul
transloc
cycl
could
examin
presenc
upstream
duplex
help
illustr
mechan
stimul
attenu
outbreak
sarscov
asia
follow
emerg
merscov
kingdom
saudi
arabia
year
later
virologist
epidemiologist
predict
novel
human
coronavirus
emerg
due
rapid
mutat
viral
genom
zoonot
featur
unfortun
approv
vaccin
sar
mer
therefor
develop
antivir
strategi
rapid
respons
emerg
coronaviru
infect
import
antivir
approach
viral
prf
target
downstream
stimul
although
smallmolecul
drug
provid
uptak
advantag
detail
structur
inform
stimul
rna
need
approach
unfortun
high
resolut
prf
stimul
structur
hcov
avail
recent
threedimension
rna
structur
model
sarscov
prf
stimul
pseudoknot
combin
computeraid
drug
librari
model
screen
help
identifi
potenti
lead
inhibit
sarscov
prf
howev
propos
bind
pocket
lead
seem
specif
sarscov
pseudoknot
stimul
altern
approach
use
complementari
pna
disrupt
sarscov
prf
stimul
pseudoknot
also
achiev
antivir
effect
suppress
propag
sarscov
replicon
tag
cellperm
peptid
facilit
cellular
deliveri
howev
approach
still
requir
inform
viral
prf
stimul
boundari
may
deliver
time
contrast
upstream
duplex
approach
provid
straightforward
mean
inhibit
prf
depend
viral
pathogen
target
viral
downstream
stimul
applic
soon
slipperi
sequenc
inform
emerg
hcov
avail
furthermor
find
antisens
dnamedi
upstream
duplex
prf
inhibit
vitro
translat
system
make
earli
stage
analysi
much
afford
access
expens
modifi
oligonucleotid
need
although
nucleic
acidbas
therapi
still
infanc
recent
posit
result
applic
modifi
oligonucleotid
expand
trinucleotid
repeat
huntington
diseas
vivo
protect
postexposur
lethal
ebola
viru
infect
demonstr
power
potenti
therapeut
agent
process
aim
facilit
cellular
deliveri
nucleic
acidbas
therapeut
agent
use
differ
oligonucleotid
modif
lipid
nanoparticl
also
show
promis
result
doubt
deliveri
safe
vaccin
coronavirus
abil
attenu
viral
prf
intran
antisensemedi
duplex
upstream
viral
slipperi
site
thu
provid
gener
strategi
quickli
inhibit
viral
prf
replic
emerg
human
coronavirus
